Headlines

SK pharmteco to strengthen small molecule and peptide capacity with $260 million investment

SK Group’s contract development and manufacturing organization (CDMO) arm SK pharmteco is spending $260 million to expand its small molecule and peptide manufacturing muscle in South Korea.

LoQus23 Therapeutics raises £35m to advance therapy for Huntington’s disease

The proceeds of the financing will support the development of LoQus23’s lead candidate, a small molecule inhibitor that is expected to enter the clinic in 2026.

Paid for and in partnership with Lonza Small Molecules

AI transforms route scouting for faster drug synthesis

Applying AI-enabled route scouting services allows drug developers to avoid pitfalls that can typically occur in drug synthesis, speeding up drug substance IND.

Stevanato to launch Vertiva 10mL on-body system at CPHI 2024

CPHI 2024: Stevanato to unveil large-volume injectable platform

The company, a provider of drug containment and delivery solutions, will introduce its expanded Vertiva 10mL on-body delivery system.

Ardena debuts new nanomedicines facility at CPHI 2024

At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch of a state-of-the-art nanomedicines GMP facility in Oss, Netherlands.

Symbiosis expands sterile manufacturing with new facility and innovations

As CPHI Milan 2024 approaches, Symbiosis Pharmaceutical Services is gearing up to showcase major expansions and innovations in sterile biopharmaceutical manufacturing.

Quotient Sciences expands with mRNA Focus at CPHI 2024

During the show, Quotient Sciences CEO Thierry Van Nieuwenhove will share insights on how the company is adapting to new FDA regulations.

CBD-based formulations from dsm-firmenich at CPHI 2024

At this October’s CPHI event being held in Milan, dsm-firmenich, is inviting stakeholders across the pharmaceutical market to immerse themselves in its patient-inspired innovations.

SGD Pharma to showcase new glass packaging solutions at CPHI 2024

The company will introduce its innovative siliconized moulded glass vials, positioning itself as the only global supplier offering this technology to pharmaceutical standards.